The ECA Interest Groups aim at supporting pharmaceutical industry and authorities by interpreting current GMP requirements. For that purpose they develop and release guidelines and SOPs which are available to ECA Members at not costs. Most Guides are available for download after registration (at no costs) for an ECA Interest Group or Association. Some Guides are only available for full ECA Members. Please find more information below about how to obtain the documents.
European QP Association
The EU Directives and the EU Guide to GMP define some detailed requirements to
be met by the Qualified Person (QP). These requirements have been extracted from
the relevant documents and are summarized in a Good Practice Guide developed by the European QP Association. A number of responsibilities as well as requirements for continuous training for QPs are not defined in detail in the EU Directive and Guides. This Good Practice Guide – considered a "living document" – gives recommendations to QPs. The Guide is available for download if you register for the Association.
ECA Good Practice Guide No. 2 "Duties, Responsibilities and Continuous Training for Qualified Persons in the EU"
Pharmaceutical Microbiology Group
The group was founded as Rapid Microbiological Methods (RMM) Working Group on 7 June 2006. It reviewed the current situation of RMM in Europe. In the following years it supported group members with current information about the development, implementation and validation of RMM. To move forward to a harmonised thinking, the group further provided literature lists, best practice papers and guideline lists on its website. Today the scope of the activity is broader. Therefore the group was renamed to Pharmaceutical Microbiology Group. Its paper/guidance document is available for download if you register for the Group.
ECA Best Practice Papers and Guidance documents on Pharmaceutical Microbiology
Analytical Quality Control Group
Since the publication of FDA´s Process Validation Guidance in 2011, validation has become a life cycle approach with focus on process knowledge and process understanding based on scientific sound principles. In addition, with the revision of Annex 15 of the EU GMP Guide, the EU has also been moving to modern process aspects (e.g. life cycle approach). The ECA Guide wants to provide support to both regulators and industry. On one hand, the guide contains the main elements of the new approach ("what to do"). On the other hand, it also serves as a supporting guide for the implementation ("how to do"). The Guide is available for download if you register for the Group.
ECA Good Practice Guide on Validation
It is of key importance that medicinal products are not only manufactured in a high quality in accordance with Good Manufacturing Practices, but that the quality and integrity of these products are maintained throughout the entire supply chain up to the patient. This is where Good Distribution Practice (GDP) comes into play. The GDP Interpretation Guide was published jointly by the ECA Foundation GDP Association and the Pharmaceutical Quality Group (PQG). It’s intention is to help colleagues in industry with the implementation of the EU GDP Guideline. The Guide is available for download if you register for the Association.
ECA/PQG Guidance on the Interpretation and Implementation of European Good Distribution Practice
The Code of Practice has been developed to support Responsible Persons according to EU
GDP Guide 2013/C343/01. It provides information about the responsibilities and duties of
RPs as well as recommendations for education and ongoing training. Finally an example of a
job description should help RPs to define their role in the supply chain of medicinal products. This Guide is also available for download if you register for the Association.
ECA Code of Practice for The Responsible Person for GDP
Visual Inspection Group
This group’s best-practice-paper aims at highlighting best practices for carrying out 100 % visual inspection of medicinal products for parenteral use in the pharmaceutical industry. It should be seen as addition and supplement to the monographs of the different Pharmacopoeias. Visual inspections of medicinal products for parenteral use should detect any readily identifiable visible container defects and ensure constant quality of the product in terms of absence of particular matter and/or turbidity, and correct or uniform appearance of a lyo cake. The Guide is available for download if you register for the Group.
ECA Good Practice Guide “Visual Inspection of Medicinal Products for Parenteral
Data Integrity Task Force
Data Integrity has become one of the most frequently observed GMP deviations in FDA and EU Inspections. This is why the topic is currently in the centre of attention of both regulators and industry. The ECA Guidance Document covers - among others - the roles and responsibilities of Corporate and Senior Management in Data Governance as well as the necessary Policies, Procedures and Processes. It further provides information on establishing criteria for Data Integrity and security of records based on ALCOA+Principles and on Auditing for Data Integrity and security of records. You need to be an ECA Member
to download the documents.
ECA Guidance Document - Data Governance and Data Integrity for GMP Regulated Facilities